Home Medicine Early availability of laboratory results increases same day ward discharge rates
Article
Licensed
Unlicensed Requires Authentication

Early availability of laboratory results increases same day ward discharge rates

  • Michael P. Cornes EMAIL logo , Graham Danks , Sanna Elgaddal , Mohammed Jawad , Jayne Tonks , Elisabeth Ries , Clare Ford and Rousseau Gama
Published/Copyright: June 20, 2018

Abstract

Background:

Delayed discharge reduces hospital efficiency and inconveniences patients. Most hospitals discharge in the afternoon, whereas the most common admission time is mid-morning. Consequently, new patients wait for the beds of patients who are fit to be discharged. Earlier discharge may, therefore, improve patient flow. We investigated the impact of early phlebotomy with early availability of laboratory results on patient discharge rates and discharge time.

Methods:

Discharge rates, discharge time and sample turnaround time were assessed before (1 October 2014 to 31 December 2014) and after (1 October 2015 to 31 December 2015) introduction of earlier phlebotomy with availability of laboratory results prior to the ward rounds on two surgical wards.

Results:

Following the intervention, over 95% of results were available before 8:30 am in 2015 as compared to less than 1% in 2014. Specimen turnaround times were similar in both study periods. Even after adjustment for age, gender, admission type and length of admission, the same day discharge rate was higher in 2015 compared to 2014 (60% vs. 52%; p<0.002), but time of discharge was unchanged.

Conclusions:

Early availability of blood results prior to ward rounds increased ward discharges but did not affect discharge time.


Corresponding author: Dr. Michael P. Cornes, Department of Clinical Biochemistry, Worcestershire Acute Hospitals NHS Trust, Worcestershire, United Kingdom of Great Britain and Northern Ireland, Phone: +01905 760843

Acknowledgments

Helen Latunji Royal Wolverhampton NHS Trust Information department Royal Wolverhampton NHS Trust Phlebotomy Team.

  1. Author contributions: MC, GD, RG, CF and SE designed the study. MC coordinated the study. Data were collected by ER, JT and MC. GD conceived the study. Data analysis was performed by MC and MJ. The manuscript was drafted by MC, RG, MJ and CF. All authors reviewed and added to the final draft. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Guarantor: RG.

  3. Research funding: This quality improvement project received no grant from any funding agency in the public, commercial or not-for-profit sectors. The authors received no financial support for the authorship and/or publication of this article. The Public Health Policy Evaluation Unit at Imperial College London is supported by funding from the NIHR School of Public Health Research.

  4. Employment or leadership: None declared.

  5. Honorarium: None declared.

  6. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Bryan K. Policies for reducing delayed discharge from hospital. Br Med Bull 2010;95:33–46.10.1093/bmb/ldq020Search in Google Scholar PubMed

2. National Audit Office. Inpatient admissions and Bed Management in NHS Acute Hospitals. London: Stationary Office, 2000.Search in Google Scholar

3. Khanna S, Sier D, Boyle J, Zeitz K. Discharge timeliness and its impact on hospital crowding and emergency department flow performance. Emerg Med Australas 2016;28:164–70.10.1111/1742-6723.12543Search in Google Scholar PubMed

4. Selker HP, Beshansky JR, Pauker SG, Kassirer JP. The epidemiology of delays in a teaching hospital. The development and use of a tool that detects unnecessary hospital days. Med Care 1989;27:112–29.10.1097/00005650-198902000-00003Search in Google Scholar PubMed

5. Carey MR, Sheth H, Braithwaite RS. A prospective study of reasons for prolonged hospitalizations on a general medicine teaching service. Gen Intern Med 2005;20:108–15.10.1111/j.1525-1497.2005.40269.xSearch in Google Scholar PubMed PubMed Central

6. Silva SA, Valácio RA, Botelho FC, Amaral CF. Reasons for discharge delays in teaching hospitals. Rev Saude Publica 2014;48:314–21.10.1590/S0034-8910.2014048004971Search in Google Scholar PubMed PubMed Central

7. Hendy P, Patel JH, Kordbacheh T, Laskar N, Harbord M. In-depth analysis of delays to patient discharge: a metropolitan teaching hospital experience. Clin Med 2012;12:320–3.10.7861/clinmedicine.12-4-320Search in Google Scholar PubMed PubMed Central

8. Majeed MU, Williams DT, Pollock R, Amir F, Liam M, Foong KS, et al. Delay in discharge and its impact on unnecessary hospital bed occupancy. BMC Health Serv Res 2012;12:410.10.1186/1472-6963-12-410Search in Google Scholar PubMed PubMed Central

9. First steps in improving phlebotomy: the challenge to improve quality, productivity and patient experience. http://www.apho.org.uk/resource/view.aspx?RID=171742. Accessed: 6 Apr 2017.Search in Google Scholar

10. Ou L, Young L, Chen J, Santiano N, Baramy LS, Hillman K. Discharge delay in acute care reasons and determinants of delay in general ward patients. Aust Health Rev 2009;33:513–21.10.1071/AH090513Search in Google Scholar

11. Conway R, Murray FE. Assessment of service delays and impact on bed utilisation in a major teaching hospital. Ir J Med Sci 2011;180:533–5.10.1007/s11845-010-0648-2Search in Google Scholar PubMed

Received: 2018-03-12
Accepted: 2018-05-23
Published Online: 2018-06-20
Published in Print: 2018-10-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. New biomarkers and traditional cardiovascular risk scores: any crystal ball for current effective advice and future exact prediction?
  4. Reviews
  5. Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes
  6. Updated review of postmortem biochemical exploration of hypothermia with a presentation of standard strategy of sampling and analyses
  7. Long non-coding RNA-mediated regulation of signaling pathways in gastric cancer
  8. Opinion Paper
  9. Long story short: an introduction to the short-term and longterm Six Sigma quality and its importance in laboratory medicine for the management of extra-analytical processes
  10. EFLM Paper
  11. The European Federation of Clinical Chemistry and Laboratory Medicine syllabus for postgraduate education and training for Specialists in Laboratory Medicine: version 5 – 2018
  12. General Clinical Chemistry and Laboratory Medicine
  13. Early availability of laboratory results increases same day ward discharge rates
  14. Evaluation of the clinical implementation of a large-scale online e-learning program on venous blood specimen collection guideline practices
  15. Improved prospective risk analysis for clinical laboratories compensated for the throughput in processes
  16. National surveys on internal quality control for blood gas analysis and related electrolytes in clinical laboratories of China
  17. Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients
  18. A quantitative LC-MS/MS method for insulin-like growth factor 1 in human plasma
  19. Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum
  20. Anti-ganglioside antibodies: experience from the Italian Association of Neuroimmunology external quality assessment scheme
  21. Reference Values and Biological Variations
  22. Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability
  23. Establishing normal values of total testosterone in adult healthy men by the use of four immunometric methods and liquid chromatography-mass spectrometry
  24. Cancer Diagnostics
  25. Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases
  26. Cardiovascular Diseases
  27. Prognostic implications of detectable cardiac troponin I below the 99th percentile in patients admitted to an emergency department without acute coronary syndrome
  28. Osteocalcin value to identify subclinical atherosclerosis over atherosclerotic cardiovascular disease (ASCVD) risk score in middle-aged and elderly Chinese asymptomatic men
  29. Infectious Diseases
  30. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing
  31. Letter to the Editor
  32. Letter to the Editor relative to Clin Chem Lab Med 2018;56(3):360–372
  33. Update in diagnosis and management of primary aldosteronism: reply to a Letter to the Editor
  34. Can calculated total nitrogen replace Kjeldahl total nitrogen measurements in 24-h urine samples?
  35. Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis?
  36. Assessment of Architect cSystems Abbott® for the colorimetric measurement of lithium in urines and dyalisates
  37. β-Trace protein in hemodialysis – comparison of different therapy modalities and high flux dialyzers
  38. Orbitrap™ high-resolution mass spectrometry for the identification of amoxicillin crystalluria
  39. High fluorescence cell count in ascitic body fluids for carcinomatosis screening
  40. The International Society for Enzymology: a glorious history, a golden legacy
  41. Congress Abstracts
  42. 10th National Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine
  43. 5th EFLM-UEMS European Joint Congress in Laboratory Medicine
Downloaded on 4.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2018-0261/html
Scroll to top button